November 03, 2025 a 11:43 am

CVS: Fundamental Ratio Analysis - CVS Health Corporation

CVS Health Corporation Stock Analysis

The CVS Health Corporation stock showcases a stable position within the healthcare sector. With a broad spectrum of services ranging from health insurance to retail pharmacy, CVS’s balanced approach provides resiliency, albeit with modest growth expectations due to market competition. Investors should consider both the defensive nature and the economic pressures on pricing and margins.

Fundamental Rating

The overall fundamental rating for CVS Health Corporation is solid, indicating a well-balanced financial position, although certain areas like debt management require attention.

Category Score Visualization
Discounted Cash Flow 5
Return on Equity 2
Return on Assets 4
Debt to Equity 1
Price to Earnings 1
Price to Book 4

Historical Rating

Evaluating CVS's historical performance helps to identify trends and potential improvements or areas of concern.

Date Overall DCF ROE ROA D/E P/E P/B
2025-10-31 3 5 2 4 1 1 4
Previous Period 0 5 2 4 1 1 4

Analyst Price Targets

Recent analyst forecasts suggest a positive outlook for CVS, with price targets indicating potential appreciation.

High Low Median Consensus
103 82 91 91.22
Stock Chart CVS

Analyst Sentiment

With a consensus rating of 'Buy,' CVS garners significant support from analysts, with few expecting underperformance.

Recommendation Count Distribution
Strong Buy 2
Buy 32
Hold 7
Sell 0
Strong Sell 0

Conclusion

CVS Health Corporation demonstrates a robust position in the healthcare sector with a diverse product and service line-up. While fundamental ratings highlight some areas for improvement, particularly in debt management, the stock holds potential for stable returns. Analyst sentiment largely favors a 'Buy' stance, supported by positive price targets. Investors should weigh these factors alongside broader economic conditions and competitive pressures within the industry.